References
- Talback M, Stenbeck M, Rosen M, et al. Cancer survival in Sweden 1960–1998–developments across four decades. Acta Oncol. 2003;42:637–659.
- DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–271.
- Walters S, Benitez-Majano S, Muller P, et al. Is England closing the international gap in cancer survival? Br J Cancer. 2015;113:848–860.
- Foukakis T, Fornander T, Lekberg T, et al. Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden. Breast Cancer Res Treat. 2011;130:553–560.
- Fredholm H, Magnusson K, Lindstrom LS, et al. Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Res Treat. 2016;160:131–143.
- Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48:27–33.
- Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993;341:973–978.
- Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909–919.
- Curigliano G, Burstein HJ, E PW, et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017;28:1700–1712.
- Tejler G, Norberg B, Dufmats M, et al. Survival after treatment for breast cancer in a geographically defined population. Br J Surg. 2004;91:1307–1312.
- Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101–121.
- Sobin L, Gospodarowicz MK, Wittekind C. Breast tumours. In: Sobin L, Gospodarowicz MK, Wittekind C, editors. UICC International Union Against Cancer TNM classification of malignant tumours. Medicinaregatan 18 G: Wiley-Blackwell; 2009. p. 181–193.
- Chen L, Linden HM, Anderson BO, et al. Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage. Breast Cancer Res Treat. 2014;147:609–616.
- Andersson TM, Rutherford MJ, Humphreys K. Assessment of lead-time bias in estimates of relative survival for breast cancer. Cancer Epidemiol. 2017;46:50–56.
- Sheridan W, Scott T, Caroline S, et al. Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time? Breast Cancer Res Treat. 2014;147:617–629.
- Kvale R, Myklebust TA, Engholm G, et al. Prostate and breast cancer in four Nordic countries: a comparison of incidence and mortality trends across countries and age groups 1975-2013. Int J Cancer. 2017;141:2228–2242.
- Brandt J, Garne JP, Tengrup I, et al. Age at diagnosis in relation to survival following breast cancer: a cohort study. World J Surg Onc. 2015;13:33.
- Saadatmand S, Bretveld R, Siesling S, et al. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients. BMJ. 2015;351:h4901.
- Park JH, Anderson WF, Gail MH. Improvements in US breast cancer survival and proportion explained by tumor size and estrogen-receptor status. Jco. 2015;33:2870–2876.
- Baburin A, Aareleid T, Padrik P, et al. Time trends in population-based breast cancer survival in Estonia: analysis by age and stage. Acta Oncol. 2014;53:226–234.